Bibliography

Pharmaceutical Policy Processes in Sierra Leone

One way to compare the behaviour of state agencies is to analyse the political processes at work in selecting and implementing policies in specific areas. This paper examines the behaviour of various participants in drug policy processes in Sierra Leone. After commenting on some general features of the relations between transnational pharmaceutical companies and governments in less developed countries, the paper turns to the case of Sierra Leone. Data from interviews, budgetary allocations, and national development plans are combined with an account of institutional structures and procedures in an explanation of the origins and limitations of the attempt to reform government drug purchasing. Special attention is paid to the efforts of a public official to restrict government purchases to a list of ‘relatively essential’ drugs. Additional policy changes are proposed that could build on this national formulary to enhance the availability of medicines to users of the public health system. – Bibliogr., sum. in French.

Title: Pharmaceutical Policy Processes in Sierra Leone
Author: Grieve, Malcolm J.
Year: 1985
Periodical: Canadian Journal of African Studies
Volume: 19
Issue: 3
Pages: 589-613
Language: English
Geographic term: Sierra Leone
External link: https://www.jstor.org/stable/484517
Abstract: One way to compare the behaviour of state agencies is to analyse the political processes at work in selecting and implementing policies in specific areas. This paper examines the behaviour of various participants in drug policy processes in Sierra Leone. After commenting on some general features of the relations between transnational pharmaceutical companies and governments in less developed countries, the paper turns to the case of Sierra Leone. Data from interviews, budgetary allocations, and national development plans are combined with an account of institutional structures and procedures in an explanation of the origins and limitations of the attempt to reform government drug purchasing. Special attention is paid to the efforts of a public official to restrict government purchases to a list of ‘relatively essential’ drugs. Additional policy changes are proposed that could build on this national formulary to enhance the availability of medicines to users of the public health system. – Bibliogr., sum. in French.